Printer Friendly

WESTLAKE COMP. CANCER CENTER TO ESTABLISH BONE MARROW TRANSPLANTATION, STEM CELL PHERESIS PROGRAM UNDER DIRECTION OF ROBERT GALE, M.D., PH.D.

 LOS ANGELES, Aug. 5 /PRNewswire/ -- Westlake Comprehensive Cancer Center, a co-venture between Universal Health Services Inc. and Salick Health Care Inc. (NASDAQ: SHCI), today announced the establishment of a major bone marrow transplantation and stem cell pheresis program at its Comprehensive Cancer Center in Westlake, Calif., under the direction of Dr. Robert Peter Gale.
 Gale was recently appointed as corporate director of Bone Marrow Transplantation and Stem Cell Pheresis programs for Salick Health Care. Gale will lead the expansion of the company's existing services in these areas beginning with the program at the Westlake Comprehensive Cancer Center. The program is scheduled to be operational within the next several months.
 Alan Miller, chairman and chief executive officer of Universal Health Services, said, "I am delighted by the level of scientific and clinical expertise being established at our Westlake Comprehensive Cancer Center. The addition of a physician/scientist with the international reputation of Dr. Gale will advance our goal of establishing a new standard for cancer care in this community."
 Dr. Bernard Salick, chairman and chief executive officer, said, "The bone marrow transplant program we are creating at the Westlake Center is an important step for the company and demonstrates our commitment to providing innovative therapies in cancer diagnosis and treatment at state-of-the-art facilities. The Westlake Cancer Center is our first center to have a dedicated inpatient unit, which will enable us to offer the broadest range of cancer care services available in Southern California, and will serve as a prototype for future new or expanded centers.
 "We are particularly pleased that Dr. Gale, an international expert in cancer treatment and bone marrow transplantation, has joined us to develop these new programs," Salick added.
 "Intensive therapy, including bone marrow and stem cell transplantation, is increasingly used to treat cancer," said Gale. "In many instances, these approaches are more effective, and save more lives, than conventional cancer therapy.
 "One of our primary goals is to provide these new medical therapies to the many thousands of persons who need them, in a quality, cost- effective manner. We can accomplish this by consolidating the extensive resources of Salick Health Care and its affiliated medical and scientific network in a nationwide, coordinated, bone marrow and stem cell transplant program."
 Gale, widely recognized as the world expert in dealing with radiation accidents, was instrumental in developing the bone marrow transplantation program at the University of California, Los Angeles.
 Gale received his M.D. from the State University of New York and his Ph.D. in immunology from the University of California, Los Angeles. He is the chairman of the Scientific Advisory Committee of the International Bone Marrow Transplant Registry, a scientific network of more than 230 transplant centers worldwide. Gale has published more than 700 scientific papers and 20 books on various medical issues and also writes on nuclear and Soviet issues. He is most widely known for his leading an international team of scientists and physicians to treat victims of the nuclear accidents in Chernobyl and Brazil.
 Salick Health Care is a leading provider of diagnostic and therapeutic services to patients with complex, chronic illnesses requiring sophisticated long-term care, principally in the areas of cancer, kidney failure, organ transplantation and other immune deficiency diseases. The company provides these services at alternate sites, including outpatient facilities (hospital-based and freestanding), selected inpatient sites and patients' homes.
 Salick currently operates nine Comprehensive Cancer Centers throughout the United States and is scheduled to open a 10th center in Westlake in September. The company also operates eight outpatient dialysis centers and provides inpatient dialysis services at 21 hospitals. Through its INFUSX subsidiary, Salick provides infusion, nutritional, and related services in the patient's home and at specialized outpatient facilities.
 -0- 8/5/93
 /EDITOR'S NOTE: For information on Salick by fax, dial 800-PRO-INFO, ext. 131./
 /CONTACT: Leslie Bell, CFO & executive VP of Salick Health Care, 213-966-3410; or Nick Farina (Chicago), 312-266-7800, or John Shaw (Los Angeles), 818-783-2400, both of The Financial Relations Board/
 (SHCI)


CO: Westlake Comprehensive Cancer Center; Universal Health Services
 Inc.; Salick Health Care Inc. ST: California IN: HEA SU: JVN PER


BP-LS -- LA008 -- 9728 08/05/93 09:06 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 5, 1993
Words:691
Previous Article:KMART CORPORATION REPORTS JULY SALES INCREASE
Next Article:GLENDALE FEDERAL BANK ANNOUNCES REVISED TERMS FOR RECAPITALIZATION
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters